Leon Overview

  • Founded
  • 2010

  • Status
  • Private

  • Employees
  • 17

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

Leon General Information


Developer of drugs through nanoscience designed to offer better patient outcomes. The company's drugs specialize in improving the bioavailability of poorly water-soluble medicine by using their proprietary technology to create either polymeric or crystalline nanoparticles, enabling medical professionals to get nano-formulated drugs with meaningful differentiation and added benefits.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Kopernikusstraße 9
  • 81679 Munich
  • Germany
+49 089 000000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jul-2020 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 16-Apr-2020 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 27-Jul-2015 $20.5M $20.5M 0000 Completed Generating Revenue
To view Leon’s complete valuation and funding history, request access »

Leon Comparisons

HQ Location
Total Raised
Post Valuation
Developer of drugs through nanoscience designed to offer better patient outcomes. The company's drugs specialize in impr
Drug Discovery
Munich, Germany
17 As of 2022
00000000000 000.00


uptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
0000 000000000
Jersey City, NJ
00 As of 0000
00000000 00000


or incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis no
Waltham, MA
00 As of 0000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Leon Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Scynexis Formerly VC-backed Jersey City, NJ 00 00000 00000000 00000
0000000 0000000000 Corporate Backed or Acquired Waltham, MA 00 00000 000000&0 00000
000000000 Corporate Backed or Acquired Saint-Julien- en-Genevois, France 00 000.00 000000&0 000.00
000000 00000000000 Corporate Backed or Acquired Richmond, CA 000000000 -
000000000 00000000 Formerly VC-backed Vancouver, Canada 000 000.00 000000&0 000.00
You’re viewing 5 of 15 competitors. Get the full list »

Leon Patents

Leon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4008322-A1 Nanometer sized lecithin particles for parenteral administration Pending 25-May-2020 0000000000 0
EP-3915546-A1 Use of acid as solvent for precipitations Pending 25-May-2020 0000000000 0
EP-3915544-A1 Method for producing a liposome dispersion Inactive 25-May-2020 0000000000 0
EP-3915673-A1 Method for checking the operability of a system for the production of nanoparticles by selective precipitation from supersaturated solutions Inactive 25-May-2020 000000000 0
CA-3139380-A1 Method for producing nanoparticles Pending 16-May-2019 A61K9/5123
To view Leon’s complete patent history, request access »

Leon Executive Team (9)

Name Title Board Seat Contact Info
Andrea Cusack Chief Executive Officer
Christian Nafe Chief Financial Officer
Wolfgang Beier Co-Founder & Chief Scientific Officer
Frank Stieneker Chief Scientific and Innovation Officer
Anne Burger Director of Finance
You’re viewing 5 of 9 executive team members. Get the full list »

Leon Board Members (12)

Name Representing Role Since
Cornelia Beier Leon Co-Founder & Board Member 000 0000
Enno Spillner Evotec Supervisory Board Member 000 0000
Frank Mathias Ph.D Self Supervisory Board Member 000 0000
Gerhard Ries Ph.D LifeCare Partners Supervisory Board Member 000 0000
Hubert Birner Ph.D TVM Capital Life Science Chairman of the Supervisory Board 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Leon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leon Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BayBG Bayerische Beteiligungsgesellschaft PE/Buyout Minority 000 0000 000000 0
BayBG Venture Capital Venture Capital Minority 000 0000 000000 0
Eckenstein-Geigy-Stiftung Not-For-Profit Venture Capital Minority 000 0000 000000 0
Evotec Corporation Minority 000 0000 000000 0
Albany Private Equity Holding Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »